首页> 外文期刊>Pediatric Health, Medicine and Therapeutics >Role of pulse oximetry in detecting critical congenital heart disease among newborns delivered at a high altitude setting in Ethiopia
【24h】

Role of pulse oximetry in detecting critical congenital heart disease among newborns delivered at a high altitude setting in Ethiopia

机译:脉搏血氧仪在埃塞俄比亚高海拔地区分娩的新生儿中检测关键先天性心脏病的作用

获取原文
       

摘要

Background: Congenital heart disease is one of the most common birth defects. It is not detected in some newborns until after their hospital discharge. Pulse oximetry (SpO2) screening for critical congenital heart disease (CCHD) is practiced in some settings, mainly based on evidence derived from studies done in lowland areas. This study aimed to assess the role of SpO2 screening performed before discharge in detecting CCHD in our setting (Addis Ababa) which is located at high altitude. Methods: Oxygen saturation of 941 apparently healthy term newborns in the nursery unit of St Paul’s Hospital Millennium Medical College located in Addis Ababa, was measured before discharge during the period from January 2018 to July 2018. SpO2 reading ≥95% was taken as a negative screening result. Positive SPO2 was defined as SpO2 90% in any extremity, or a persistent SpO2 of 90%–94% in both right arm and lower extremity sites on three measurements or a persistent right arm to lower extremity SpO2 difference of 3%. Subsequent confirmatory echocardiography examination was done for those who tested positive during the SpO2 screening test. Data were analyzed using Statistical Package for Social Sciences version 20.0. Results: A total of 56/941 (6.0%) newborns tested positive during the screening test. Of those 56 cases, subsequent echocardiography examination detected persistent pulmonary hypertension of the newborn (PPHN) in ten (17.9%) cases (subsequently two of them were found to have sepsis), patent ductus arteriosus in eleven (19.6%) cases, and atrial septal defect in two (3.6%) cases. No case of CCHD was detected among the screened newborns. Conclusion: SpO2 screening detected non-cardiac causes of hypoxemic illnesses (sepsis and PPHN) which otherwise would have been missed. However, we recommend a larger sample size study to assess the efficacy of SpO2 screening in detecting CCHD in our setting.
机译:背景:先天性心脏病是最常见的出生缺陷之一。在某些新生儿中,直到出院后才发现。严重先天性心脏病(CCHD)的脉搏血氧饱和度(SpO2)筛查在某些情况下进行,主要基于在低地地区进行的研究得出的证据。这项研究旨在评估出院前进行的SpO2筛查在我们位于高海拔地区(亚的斯亚贝巴)的CCHD检测中的作用。方法:对亚的斯亚贝巴圣保罗医院千禧医学院的托儿所中941名明显健康足月新生儿的血氧饱和度进行了测定,方法是在2018年1月至2018年7月出院前进行测量。SpO2读数≥95%被视为阴性筛选结果。阳性SPO2定义为在任何肢体中SpO2 <90%,或者在三个测量结果中在右臂和下肢部位的持续SpO2在90%–94%,或者持续性右臂与下肢的SpO2差异大于3%。随后对在SpO2筛查测试中呈阳性的患者进行了确诊超声心动图检查。使用社会科学统计软件包20.0版分析数据。结果:共有56/941(6.0%)新生儿在筛查测试中呈阳性。在这56例病例中,随后的超声心动图检查发现新生儿持续性肺动脉高压(PPHN)占10例(17.9%)(随后发现其中有2例患有败血症),动脉导管未闭11例(19.6%)和心房间隔缺损2例(3.6%)。在筛查的新生儿中未检测到CCHD病例。结论:SpO2筛查可以检测出非心脏原因的低氧血症(败血症和PPHN),否则会被遗漏。但是,我们建议进行更大样本量的研究,以评估SpO2筛查在我们环境中检测CCHD的功效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号